Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medtronic/Physio-Control

This article was originally published in The Gray Sheet

Executive Summary

Federal Trade Commission is requesting additional information in connection with its review of the two companies' proposed merger. Medtronic, which announced June 29 a definitive stock-swap agreement to purchase Physio-Control for $538 mil. ("The Gray Sheet" July 6, p. 3), does not anticipate the Commission's request will delay a proposed fall completion date for the transaction, the company reports Aug. 13

Latest Headlines
See All
UsernamePublicRestriction

Register

MT010506

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel